FDA Release - Search News

Order byBest matchMost fresh

New COVID vaccine approved by US FDA

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE

mRNA-1283 showed a 9.3% higher relative vaccine efficacy (rVE) compared to mRNA-1273 in individuals aged 12 years and older, and in a descriptive sub-group analysis, a 13.5% higher rVE in adults aged...

Axios on MSN · 7h

FDA approves new Moderna COVID-19 vaccine

Mother Jones · 1h

The FDA Just Approved a New Covid Vaccine

· 1d

FDA Chief: COVID Vaccine in Pregnancy Should Be Personal Choice

Federal health officials have pulled back a key recommendation that pregnant women get the COVID-19 vaccine — causing sharp criticism from doctors and other experts.

· 1d

US CDC keeps recommendation of COVID vaccines for healthy kids

· 1d

Covid-19 shots for healthy children remain on CDC vaccine schedule despite Kennedy’s pledge to remove them

· 1d

C.D.C. Contradicts Kennedy and Keeps Advice That Children May Get Covid Shots

The official C.D.C. position for pregnant women is “no guidance,” according to a communication released from the agency Friday.

· 1d

CDC removes language that says healthy kids should get COVID shots

· 1d

CDC updates COVID vaccine recommendations, but not how RFK Jr. wanted

Targeted Oncology1d

FDA BLA Pulled for Patritumab Deruxtecan in EGFR+ NSCLC

The FDA biologics license application for patritumab deruxtecan in EGFR+ NSCLC has been withdrawn following discussions with the agency.

Health Affairs1d

Podcast: FDA Vague Efforts to Scale Generative AI Internally By End of June

Health Affairs' Jeff Byers welcomes Senior Editor Michael Gerber back to the program to discuss the Food and Drug Administration's recent announcement to scale a generative artificial intelligence across its center in the future.

Managed Healthcare Executive2d

FDA Approves Alcon’s Tryptyr for Dry Eye Disease

Alcon, a global eye care company known for products such as Systane and GenTeal Tears, plans to launch Tryptyr in the U.S. market in the third quarter of 2025. International rollouts are expected to follow.

Fierce Biotech2d

Daiichi, Merck pull HER3-DXd filing at FDA after confirmatory trial misses survival endpoint

After Merck paid a hefty sum to co-develop and co-commercialize HER3-DXd, the drug has suffered notable setbacks in consecutive years.

The Heartland Institute4d

FDA to Phase Out Synthetic Food Dyes

The U.S. Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) plan to phase out all petroleum-based synthetic dyes from food and drugs in the United States by the end of 2026.